Polsinelli’s Corporate and Transactional practice is built for the middle market — guiding companies and investors from growth and acquisition to exit and beyond.

Consistently ranked among the most active M&A and private equity firms in the U.S. by Mergermarket and PitchBook, we combine national deal volume with disciplined execution and senior-level attention to every engagement.

We manage the transactions and strategic corporate matters that shape a company’s trajectory: platform and bolt-on acquisitions, strategic sales, recapitalizations, governance and ongoing outside general counsel support. Senior lawyers stay engaged; deal teams keep deals moving; and integrated subject matter and industry counsel ensures decisions align with long-term business goals. We get deals done — and we stay to help them succeed.

Many of our client relationships span decades and multiple transactions, reflecting the continuity of our work across sponsors, portfolio companies and operating businesses. We advise middle market enterprises at inflection points — acquisitions, expansion, generation succession, governance transitions and strategic exits — and remain engaged as long-term corporate counsel as those businesses evolve.

Our experience spans health care, technology, financial services, manufacturing and industrial services, consumer-facing businesses and real estate-adjacent sectors. Across industries, clients turn to us for practical judgment, expert guidance, efficient staffing and steady counsel through the full arc of the business lifecycle.

Read More
At a Glance
National Recognition
Slide 1 of 4
Publications
All Publications
California Attorney General and California Medical Association Advocate for Competing Interpretations of Corporate Practice of Medicine Laws That May Reshape PC/MSO Structures
Key Takeaways The pending Art Center case could significantly reshape California’s “friendly PC” / PC-MSO model, particularly regarding whether MSOs can remove and replace physician shareholders. The California AG and CMA present competing interpretations of CPOM: the AG favors a strict prohibition on removal rights, while the CMA supports a fact-specific analysis focused on actual control over clinical decision-making. Health care stakeholders should proactively review and potentially revise PC/MSO agreements, as increased enforcement risk and evolving legal standards may render common provisions — especially physician removal rights — unlawful. Two amicus briefs filed in a matter before the California Court of Appeal illustrate potential futures for the friendly PC structure and enforcement against the corporate practice of medicine (CPOM). On March 30, 2026, the California
Read More
The Antitrust Scrutiny Continues: FTC Launches New Healthcare Task Force
Key Takeaways The FTC has launched a new Healthcare Task Force to coordinate enforcement across its bureaus and increase focus on the health care industry Expect heightened scrutiny of health care consolidation and business practices, with a particular focus on pricing, quality and anticompetitive conduct Increased collaboration between the FTC, DOJ and HHS may lead to more coordinated and expansive enforcement actions In March 2026, FTC Chairman Andrew Ferguson released a memorandum directing leaders of the various bureaus of the FTC to form a “Healthcare Task Force.” The stated purpose of the Task Force is to unify the resources and knowledge of the different branches to better pursue the FTC’s initiatives in health care. Accordingly, the Task Force seeks to unify the focus of
Read More